Predictive ability of serum high-molecular-weight adiponectin in combination with serum insulin and serum C-reactive protein for the presence of metabolic syndrome

References

• Alberti KGM, Zimmet P, Shaw J. 2005. The metabolic syndrome: a new worldwide definition. Lancet. 366:1059–1062.
   PubMed Web of Science ®Google Scholar
• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 257:79–83.
   PubMed Web of Science ®Google Scholar
• Berg AH, Combs TP, Scherer PE. 2002. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 13:84–89.
   PubMed Web of Science ®Google Scholar
• Berkman LF, Breslow L. 1983. Health and ways of living. New York: Oxford University Press.
   Google Scholar
• Bray GA, Bellanger T. 2006. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 29:109–117.
   PubMed Web of Science ®Google Scholar
• Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O'Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, Moller DE. 2002. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology. 143:998–1007.
   PubMed Web of Science ®Google Scholar
• Dullaart RP, de Vries R, van Tol A, Sluiter WJ. 2007. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. Eur J Endocrinol. 156:387–394.
   PubMed Web of Science ®Google Scholar
• Fujimatsu D, Kotooka N, Inoue T, Nishiyama M, Node K. 2009. Association between high molecular weight adiponectin levels and metabolic parameters. J Atheroscler Thromb. 16:553–559.
   PubMedGoogle Scholar
• Gable DR, Hurel SJ, Humphries SE. 2006. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis. 188:231–244.
   PubMed Web of Science ®Google Scholar
• Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. 2006. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 29:1357–1362.
   PubMed Web of Science ®Google Scholar
• Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, Mantzoros CS, Hu FB. 2008. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med. 149:307–316.
   PubMed Web of Science ®Google Scholar
• Herder C, Hauner H, Haastert B, Rohrig K, Koenig W, Kolb H, Muller-Scholze S, Thorand B, Holle R, Rathmann W. 2006. Hypoadiponectinemia and proinflammatory state: two sides of the same coin?: results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4). Diabetes Care. 29:1626–1631.
   PubMed Web of Science ®Google Scholar
• Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H, Saito I. 2010. Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb. 17:1201–1211.
   PubMed Web of Science ®Google Scholar
• Hung J, McQuillan BM, Thompson PL, Beilby JP. 2008. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Lond). 32:772–779.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation (IDF). 2006. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Available online at: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf, accessed February 1, 2012..
   Google Scholar
• Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 116:1784–1792.
   PubMed Web of Science ®Google Scholar
• Kuo SM, Halpern MM. 2011. Lack of association between body mass index and plasma adiponectin levels in healthy adults. Int J Obes (Lond). 35:1487–1494.
   PubMed Web of Science ®Google Scholar
• Li S, Shin HJ, Ding EL, van Dam RM. 2009. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 302:179–188.
   PubMed Web of Science ®Google Scholar
• Libby P, Okamoto Y, Rocha VZ, Folco E. 2010. Inflammation in atherosclerosis: transition from theory to practice. Circ J. 74:213–220.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, Sugiura K, Kondo T, Murohara T, Toyoshima H. 2006. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol. 26:871–876.
   PubMedGoogle Scholar
• National Cholesterol Education Program (NCEP). 2002. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Saisho Y, Hirose H, Seino Y, Saito I, Itoh H. 2010. Usefulness of C-reactive protein to high-molecular-weight adiponectin ratio to predict insulin resistance and metabolic syndrome in Japanese men. J Atheroscler Thromb. 17:944–952.
   PubMedGoogle Scholar
• Seino Y, Hirose H, Saito I, Itoh H. 2007. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism. 56:1493–1499.
   PubMed Web of Science ®Google Scholar
• Seino Y, Hirose H, Saito I, Itoh H. 2009. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism. 58:355–360.
   PubMed Web of Science ®Google Scholar
• Tsao TS, Lodish HF, Fruebis J. 2002. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol. 440:213–221.
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Rumley A, Brown K, Cherry L, Sattar N. 2007. Associations of adiponectin with metabolic and vascular risk parameters in the British regional heart study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters. Int J Obes (Lond). 31:1089–1098.
   PubMed Web of Science ®Google Scholar